Roche bags CE Mark for automated mass spectrometry antibiotics monitoring
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
LNK01006 is designed to deliver potent, selective inhibition of TYK2-mediated cytokine signaling with central nervous system exposure
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
The successful refinancing and enhancement of the syndicated credit facilities provides access to an additional CHF 40 million
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible
Subscribe To Our Newsletter & Stay Updated